Targeting immune microenvironment–mediated mesenchymal transition in glioblastoma: Molecular mechanisms and translational strategies

Neuro-Oncology Advances · Published 2026-01-01 · DOI 10.1093/noajnl/vdag075

Authors being retrieved — see the publisher record. https://doi.org/10.1093/noajnl/vdag075

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

Spatially resolved transcriptomic profiles reveal unique defining molecular features of infiltrative 5ALA-metabolizing cells associated with glioblastoma recurrence · Genome Medicine · 2023 · Cites or is cited by this article
Cognitive dysfunction associated with cellular immunotherapy for cancer · Neuro-Oncology Advances · 2026 · Same journal
The molecular profile of gliomas in adolescents and young adults · Neuro-Oncology Advances · 2026 · Same journal
Immunogenomic Profiling Reveals Targets for Gene Therapy in Pediatric Brain Tumors · Neuro-Oncology Advances · 2026 · Same journal
Emotional distress impairs immune checkpoint blockade efficacy in recurrent high-grade glioma: Insights from tumor in situ fluid analysis · Neuro-Oncology Advances · 2026 · Same journal
Mutational signature stratification of recurrent gliomas reveals distinct patterns of genomic traits · Neuro-Oncology Advances · 2026 · Same journal
Emerging blood-based biomarkers for the detection of parenchymal brain metastasis: Current progress and future perspectives · Neuro-Oncology Advances · 2026 · Same journal
ASL-based Exchange Time Mapping for Differentiation of High-Grade Glioma and Brain Metastases · Neuro-Oncology Advances · 2026 · Same journal
Disturbance of functional connectivity in patients with low grade glioma is associated with worse progression–free survival · Neuro-Oncology Advances · 2026 · Same journal
The Cell Surface Proteome of Malignant Peripheral Nerve Sheath Tumors Reveals Therapeutic Targets · Neuro-Oncology Advances · 2026 · Same journal